Treatment with antipsychotics is very common in the elderly and often indispensable. However, for successful treatment it is essential to have an adequate multidimensional assessment of the ...

A recent functional MRI study investigated the patterns of brain activation associated with PPI in schizophrenic patients, and assessed whether the type of antipsychotic medication administered ...

Bajaj Health has also extended the offer for Pimavanserin to several leading pharma companies to ensure availability in ...

Antipsychotic drugs introduced over the past 15 years, often termed second-generation or atypical agents, were selected on the basis of a structural or pharmacological similarity to clozapine ...

Nine newer antipsychotics, called atypical antipsychotics, are used as "augmentation therapy," or add-ons to treat depression that hasn't responded to antidepressants or other treatments.

Bristol Myers Squibb plans to release initial late-stage trial data on Cobenfy in Alzheimer's-related psychosis during the ...

Bajaj Healthcare said that it has received approval from the Drug Controller General of India (DCGI) to manufacture both the API and drug formulation of Pimavanserin.

Bajaj Healthcare has received an approval from the Drug Controller General of India (DCGI) to manufacture both the API and Drug Formulation of Pimavanserin, a 34 mg capsule.

Bajaj Healthcare receives DCGI approval to manufacture Pimavanserin, a generic medication for treating hallucinations and delusions associated with Parkinson's disease.